Literature DB >> 21343827

Estimation of liver function using T1 mapping on Gd-EOB-DTPA-enhanced magnetic resonance imaging.

Takashi Katsube1, Masahiro Okada, Seishi Kumano, Masatoshi Hori, Izumi Imaoka, Kazunari Ishii, Masatoshi Kudo, Hajime Kitagaki, Takamichi Murakami.   

Abstract

OBJECTIVES: To investigate the ability of T1 mapping of liver on gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance imaging for the estimation of liver function.
MATERIALS AND METHODS: Local institutional review board approved this study. Ninety-one patients (64 men, 27 women; mean age, 67.4 years) were classified into 4 groups as follows: normal liver function (NLF), n = 16; chronic hepatitis (CH), n = 38; liver cirrhosis with Child-Pugh A (LCA), n = 20; and liver cirrhosis with Child-Pugh B (LCB), n = 17. Look-Locker sequences (single slice multiphase imaging using gradient-echo sequence with inversion recovery pulse) were obtained before and at 3, 8, 13, and 18 minutes after Gd-EOB-DTPA administration. T1 mapping of liver parenchyma was calculated from the Look-Locker sequence. T1 relaxation time of liver and reduction rate of T1 relaxation time between pre- and postcontrast enhancement were measured. The Bonferroni t test was used for comparisons between the 4 groups.
RESULTS: Precontrast T1 relaxation times were significantly longer for LCA and LCB than for NLF, and that of LCB was longer than that of chronic hepatitis (P < 0.05). Postcontrast T1 relaxation times were significantly longer for LCB than for other groups at all time points. Those of LCA were longer than those of NLF at all time points. Reduction rates were significantly lower for LCB than for the other groups at ≥8 minutes.
CONCLUSIONS: Evaluation of hepatic uptake of Gd-EOB-DTPA using T1 mapping of liver parenchyma can help estimate liver function.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21343827     DOI: 10.1097/RLI.0b013e318200f67d

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  65 in total

1.  Chronological evaluation of liver enhancement in patients with chronic liver disease at Gd-EOB-DTPA-enhanced 3-T MR imaging: does liver function correlate with enhancement?

Authors:  Shinichi Nakamura; Kazuo Awai; Daisuke Utsunomiya; Tomohiro Namimoto; Takeshi Nakaura; Kosuke Morita; Yasuyuki Yamashita
Journal:  Jpn J Radiol       Date:  2011-12-14       Impact factor: 2.374

2.  MR relaxometry of the liver: significant elevation of T1 relaxation time in patients with liver cirrhosis.

Authors:  Tobias Heye; Schu-Ren Yang; Michael Bock; Sylvia Brost; Kilian Weigand; Thomas Longerich; Hans-Ulrich Kauczor; Waldemar Hosch
Journal:  Eur Radiol       Date:  2012-02-03       Impact factor: 5.315

3.  Gd-EOB-DTPA-enhanced MRI T1 mapping for assessment of liver function in rabbit fibrosis model: comparison of hepatobiliary phase images obtained at 10 and 20 min.

Authors:  Zhi-Peng Zhou; Li-Ling Long; Li-Juan Huang; Teng-Fei Yang; Zhong-Kui Huang
Journal:  Radiol Med       Date:  2017-01-09       Impact factor: 3.469

4.  Assessing liver function by liver enhancement during the hepatobiliary phase with Gd-EOB-DTPA-enhanced MRI at 3 Tesla.

Authors:  N Verloh; M Haimerl; F Zeman; M Schlabeck; A Barreiros; M Loss; A G Schreyer; C Stroszczynski; C Fellner; P Wiggermann
Journal:  Eur Radiol       Date:  2014-02-16       Impact factor: 5.315

5.  Intraoperative simulation of remnant liver function during anatomic liver resection with indocyanine green clearance (LiMON) measurements.

Authors:  Michael N Thomas; Ernst Weninger; Martin Angele; Florian Bösch; Sebastian Pratschke; Joachim Andrassy; Markus Rentsch; Manfred Stangl; Werner Hartwig; Jens Werner; Markus Guba
Journal:  HPB (Oxford)       Date:  2015-01-08       Impact factor: 3.647

6.  Abdominal DCE-MRI reconstruction with deformable motion correction for liver perfusion quantification.

Authors:  Adam Johansson; James M Balter; Yue Cao
Journal:  Med Phys       Date:  2018-08-31       Impact factor: 4.071

7.  Potential of Gd-EOB-DTPA-enhanced MR imaging for evaluation of bile duct ligation-induced liver injury in rabbits.

Authors:  Ying Ding; Sheng-Xiang Rao; Caizhong Chen; Renchen Li; Meng-Su Zeng
Journal:  Hepatol Int       Date:  2014-12-06       Impact factor: 6.047

8.  Efficacy of liver parenchymal enhancement and liver volume to standard liver volume ratio on Gd-EOB-DTPA-enhanced MRI for estimation of liver function.

Authors:  Tomohide Yoneyama; Yoshihiko Fukukura; Kiyohisa Kamimura; Koji Takumi; Aya Umanodan; Shinichi Ueno; Masayuki Nakajo
Journal:  Eur Radiol       Date:  2013-12-20       Impact factor: 5.315

9.  Usefulness of T1 mapping on Gd-EOB-DTPA-enhanced MR imaging in assessment of non-alcoholic fatty liver disease.

Authors:  Ying Ding; Sheng-Xiang Rao; Tao Meng; Caizhong Chen; Renchen Li; Meng-Su Zeng
Journal:  Eur Radiol       Date:  2014-01-26       Impact factor: 5.315

10.  Novel Imaging Diagnosis for Hepatocellular Carcinoma: Consensus from the 5th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2014).

Authors:  Bang-Bin Chen; Takamichi Murakami; Tiffany Ting-Fang Shih; Michiie Sakamoto; Osamu Matsui; Byung-Ihn Choi; Myeong-Jin Kim; Jeong Min Lee; Ren-Jie Yang; Meng-Su Zeng; Ran-Chou Chen; Ja-Der Liang
Journal:  Liver Cancer       Date:  2015-10-15       Impact factor: 11.740

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.